Clinical Trials Browser

Terminated × Breast Neoplasms, Male × Fulvestrant × Clear all

NCT00722072 2018-02-26

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Phase 2 Terminated

12 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male